Hsiu‐Li Lin

902 total citations
33 papers, 555 citations indexed

About

Hsiu‐Li Lin is a scholar working on Surgery, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hsiu‐Li Lin has authored 33 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Neurology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hsiu‐Li Lin's work include Gastroesophageal reflux and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Eosinophilic Esophagitis (3 papers). Hsiu‐Li Lin is often cited by papers focused on Gastroesophageal reflux and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Eosinophilic Esophagitis (3 papers). Hsiu‐Li Lin collaborates with scholars based in Taiwan, United States and Slovakia. Hsiu‐Li Lin's co-authors include Hsiu‐Chen Lin, Herng‐Ching Lin, Yi‐Hua Chen, Hung‐Yi Chiou, Li‐Hsuan Wang, Chien‐Yeh Hsu, Chien‐Yeh Hsu, Yow‐Shieng Uang, Jane C.-J. Chao and Chang‐Hua Chen and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and The American Journal of Medicine.

In The Last Decade

Hsiu‐Li Lin

33 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsiu‐Li Lin Taiwan 15 140 137 108 98 82 33 555
Taner Erselcan Türkiye 17 132 0.9× 108 0.8× 109 1.0× 51 0.5× 39 0.5× 41 770
Hee Joon Yu South Korea 15 54 0.4× 63 0.5× 46 0.4× 84 0.9× 47 0.6× 55 612
Tamer Hassan Egypt 15 90 0.6× 44 0.3× 67 0.6× 48 0.5× 27 0.3× 58 648
Mehmet Keskın Türkiye 13 130 0.9× 42 0.3× 107 1.0× 118 1.2× 42 0.5× 52 697
Satoru Kobayashi Japan 13 106 0.8× 102 0.7× 20 0.2× 80 0.8× 34 0.4× 54 459
László Pótó Hungary 14 32 0.2× 73 0.5× 49 0.5× 159 1.6× 56 0.7× 40 733
Gudrun Wagenpfeil Germany 16 52 0.4× 43 0.3× 42 0.4× 89 0.9× 136 1.7× 79 746
David Corbin Barbados 13 48 0.3× 62 0.5× 28 0.3× 69 0.7× 100 1.2× 32 589
José M. Manaligod United States 15 72 0.5× 57 0.4× 38 0.4× 145 1.5× 53 0.6× 40 753

Countries citing papers authored by Hsiu‐Li Lin

Since Specialization
Citations

This map shows the geographic impact of Hsiu‐Li Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiu‐Li Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiu‐Li Lin more than expected).

Fields of papers citing papers by Hsiu‐Li Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiu‐Li Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiu‐Li Lin. The network helps show where Hsiu‐Li Lin may publish in the future.

Co-authorship network of co-authors of Hsiu‐Li Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiu‐Li Lin. A scholar is included among the top collaborators of Hsiu‐Li Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiu‐Li Lin. Hsiu‐Li Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chun‐Hao, Hsiu‐Chen Lin, Hsiu‐Li Lin, Joseph J. Keller, & Li‐Hsuan Wang. (2023). Association between Antihyperlipidemic Agent Use and Age-Related Macular Degeneration in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study. Biomedicines. 11(6). 1508–1508. 1 indexed citations
2.
Lin, Hsiu‐Li, et al.. (2022). The effects of medications for treating COPD and allied conditions on stroke: a population-based cohort study. npj Primary Care Respiratory Medicine. 32(1). 4–4. 2 indexed citations
3.
Lin, Hsiu‐Chen, et al.. (2022). Association of Angiotensin Receptor Blockers with Incident Parkinson Disease in Patients with Hypertension: A Retrospective Cohort Study. The American Journal of Medicine. 135(8). 1001–1007. 22 indexed citations
4.
Lin, Hsiu‐Chen, et al.. (2022). Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation. Frontiers in Pharmacology. 12. 805318–805318. 5 indexed citations
5.
Lin, Hsiu‐Chen, et al.. (2021). Calcium Channel blockers are associated with reduced risk of Parkinson's disease in patients with hypertension: A population-based retrospective cohort study. Journal of the Neurological Sciences. 424. 117412–117412. 18 indexed citations
6.
7.
8.
Lin, Hsiu‐Li, et al.. (2020). Urinary tract infection is associated with hypokalemia: a case control study. BMC Urology. 20(1). 108–108. 4 indexed citations
9.
Lin, Hsiu‐Li, et al.. (2017). Increased Risk of Bullous Pemphigoid after First-Ever Stroke: A Population-Based Study. Neurodegenerative Diseases. 17(4-5). 166–170. 5 indexed citations
10.
Lin, Hsiu‐Li, et al.. (2016). Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study. European Journal of Clinical Pharmacology. 73(3). 365–371. 10 indexed citations
11.
Lin, Hsiu‐Chen, Hsiu‐Li Lin, Yow‐Shieng Uang, et al.. (2016). The use of proton pump inhibitors decreases the risk of diabetes mellitus in patients with upper gastrointestinal disease. Medicine. 95(28). e4195–e4195. 18 indexed citations
12.
Lin, Hsiu‐Li, et al.. (2015). Increased Risk of Acute Pancreatitis in Patients with Rheumatoid Arthritis: A Population-Based Cohort Study. PLoS ONE. 10(8). e0135187–e0135187. 16 indexed citations
13.
Lin, Hsiu‐Li, et al.. (2015). Topiramate may not increase risk of urolithiasis: A nationwide population-based cohort study. Seizure. 29. 86–89. 9 indexed citations
14.
Chen, Chang‐Hua, et al.. (2015). Risk of cancer among HIV-infected patients from a population-based nested case–control study: implications for cancer prevention. BMC Cancer. 15(1). 133–133. 42 indexed citations
15.
Lin, Hsiu‐Li, et al.. (2014). Hip fracture after first-ever stroke: a population-based study. Acta Neurologica Scandinavica. 131(3). 158–163. 15 indexed citations
16.
Chen, Chih‐Hung, Hsiu‐Chen Lin, Hsiu‐Li Lin, et al.. (2013). Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease. Journal of Microbiology Immunology and Infection. 48(4). 390–396. 14 indexed citations
17.
Kang, Jiunn‐Horng, et al.. (2011). Increased risk of parkinsonism among patients with cirrhosis: a 7-year follow-up study. Liver International. 31(5). 685–691. 13 indexed citations
18.
Lin, Hsiu‐Li, et al.. (2010). Increased risk of colorectal cancer among patients with biliary tract inflammation: A 5‐year follow‐up study. International Journal of Cancer. 128(2). 447–452. 11 indexed citations
19.
Cheng, Yu‐Che, et al.. (2009). Chronic Pain after Tension-free Inguinal Hernia Repair. 19(2). 64–75. 1 indexed citations
20.
Chen, Yi‐Hua, Hung‐Yi Chiou, Herng‐Ching Lin, & Hsiu‐Li Lin. (2009). Affect of Seizures During Gestation on Pregnancy Outcomes in Women With Epilepsy. Archives of Neurology. 66(8). 979–84. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taner Erselcan Breakdown of academic impact, for papers by Hee Joon Yu Breakdown of academic impact, for papers by Tamer Hassan Breakdown of academic impact, for papers by Mehmet Keskın Breakdown of academic impact, for papers by Satoru Kobayashi Breakdown of academic impact, for papers by László Pótó Breakdown of academic impact, for papers by Gudrun Wagenpfeil Breakdown of academic impact, for papers by David Corbin Breakdown of academic impact, for papers by José M. Manaligod
Rankless by CCL
2026